However, recent studies demonstrated that AKR1B and AKR1C3 are highly expressed in many human cancers including prostate, neuroblastoma and lung and they are crucial to regulate cell differentiation and cancer cell proliferation as well as to mediate drug resistance (32–37). Here, AKR1C3 is linked to neuroblastoma.